Author:
Wang Dedong,Hu Xiangzhi,Xu Huan,Chen Yuanyuan,Wang Suixiang,Lin Guozhen,Yang Lei,Chen Jinbin,Zhang Lin,Qin Pengzhe,Wu Di,Liang Boheng
Abstract
IntroductionLiver cancer is one of the most common malignant gastrointestinal tumors worldwide. This study intends to provide insight into the epidemiological characteristics and development trends of liver cancer incidence and mortality from 2010 to 2020 in Guangzhou, China.MethodsData were collected from the Cancer Registry and Reporting Office of Guangzhou Center for Disease Control and Prevention. Cross-sectional study, Joinpoint regression (JPR) model, and Age-Period-Cohort (APC) model were conducted to analyze the age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) trend of liver cancer among the entire study period.ResultsThe age-standardized incidence and mortality of liver cancer in Guangzhou showed an overall decreasing trend. The disparity in risk of morbidity and mortality between the two sexes for liver cancer is increasing. The cohort effect was the most significant among those born in 1965~1969, and the risk of liver cancer incidence and mortality in the total population increased and then decreased with the birth cohort. Compared with the birth cohort born in 1950~1954 (the reference cohort), the risk of liver cancer incidence and mortality in the males born in 1995~1999 decreased by 32% and 41%, respectively, while the risk in the females decreased by 31% and 32%, respectively.ConclusionsThe early detection, prevention, clinical diagnosis, and treatment of liver cancer in Guangzhou have made remarkable achievements in recent years. However, the risk of liver cancer in the elderly and the middle-aged males is still at a high level. Therefore, the publicity of knowledge related to the prevention and treatment of liver cancer among the relevant population groups should be actively carried out to enhance the rate of early diagnosis and treatment of liver cancer and to advocate a healthier lifestyle.
Reference50 articles.
1. Liver cancer;Gravitz;Nature,2014
2. Hepatocellular carcinoma;Forner;Lancet (London England),2018
3. Hepatocellular carcinoma;Llovet;Nat Rev Dis Primers,2021
4. The global burden of liver disease;Younossi;Clin Gastroenterol Hepatol,2023
5. Dietary natural products for prevention and treatment of liver cancer;Zhou;Nutrients,2016